Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. Recalls

All product recalls associated with ANI Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

11

Past Year

0

Class I (Serious)

0

Most Recent

Feb 2022

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–11 of 11 recalls

Pyrazinamide Tablets (ANI Pharmaceuticals) – CGMP Deviation (2022)

cGMP Deviations

Class IIModerate

FDAFeb 15, 2022Nationwide• ANI Pharmaceuticals, Inc.

Alprazolam Tablets 0.5mg (ANI Pharmaceuticals) – CGMP Deviation (2022)

cGMP Deviations

Class IIModerate

FDAFeb 15, 2022Nationwide• ANI Pharmaceuticals, Inc.

Alprazolam Tablets 0.25mg (ANI Pharmaceuticals) – CGMP Deviation (2022)

cGMP Deviations

Class IIModerate

Feb 15, 2022

Nationwide

• ANI Pharmaceuticals, Inc.

Alprazolam Tablets 2.0mg (ANI Pharmaceuticals) – CGMP Deviation (2022)

cGMP Deviations

Class IIModerate

FDAFeb 15, 2022Nationwide• ANI Pharmaceuticals, Inc.

Alprazolam Tablets 1.0mg (ANI Pharmaceuticals) – CGMP Deviation (2022)

cGMP Deviations

Class IIModerate

FDAFeb 15, 2022Nationwide• ANI Pharmaceuticals, Inc.

Dextroamphetamine Mixture (ANI) – Incorrect Expiration Date (2020)

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

FDAOct 9, 2020Nationwide• ANI Pharmaceuticals, Inc.

Dextroamphetamine Saccharate (ANI Pharmaceuticals) - Incorrect Expiration Date (2020)

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

FDAOct 9, 2020Nationwide• ANI Pharmaceuticals, Inc.

Dextroamphetamine Saccharate (ANI Pharmaceuticals) - Incorrect Expiration Date (2020)

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

FDAOct 9, 2020Nationwide• ANI Pharmaceuticals, Inc.

Dextroamphetamine Saccharate (ANI Pharmaceuticals) - Incorrect Expiration Date (2020)

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

FDAOct 9, 2020Nationwide• ANI Pharmaceuticals, Inc.

Dextroamphetamine Saccharate (ANI Pharmaceuticals) - Incorrect Expiration Date (2020)

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

FDAOct 9, 2020Nationwide• ANI Pharmaceuticals, Inc.

Dextroamphetamine Saccharate (ANI Pharmaceuticals) - Incorrect Expiration Date (2020)

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

FDAOct 9, 2020Nationwide• ANI Pharmaceuticals, Inc.